An investigation into the impact of enteric coated of aspirin in patients with newly diagnosed ischemic stroke (ECASIS)

INTRODUCTION: Uncertainty remains regarding the impact of enteric-coated (EC) aspirin as it relates to the reduction of cardiovascular risk. We hypothesize that EC formulation based on a previous report may blunt aspirin response as evidenced by reduced Thromboxane A2 (TXA 2) levels in diabetic pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Elshafei, Mohamed Nabil, Imam, Yahia, Mohamed, Mouhand F.H., AlSaud, Arwa Ebrahim, Ahmed, Mohamed Sayed, Obeidat, Khaldun, Saeid, Razan, Ali, Mohamed, Abdallah, Ibtihal M., Parray, Aeijaz Sultan, Danjuma, Mohammed Ibn-Masoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254488/
https://www.ncbi.nlm.nih.gov/pubmed/32443379
http://dx.doi.org/10.1097/MD.0000000000020307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254488/
https://www.ncbi.nlm.nih.gov/pubmed/32443379
http://dx.doi.org/10.1097/MD.0000000000020307

Ejemplares similares